UnitedHealth Group (UNH) Tops Q2 EPS by 5c

Go back to UnitedHealth Group (UNH) Tops Q2 EPS by 5c

Oppenheimer Raised Price Target to $140 Following UnitedHealth Group's (UNH) EPS Beat

July 17, 2015 9:23 AM EDT

Oppenheimer maintained Outperform rating on UnitedHealth Group (NYSE: UNH), and raised the price target to $140.00 (from $133.00), following 2Q15 earnings release. UNH reported 2Q15 EPS of $1.64 vs. Street consensus of $1.58.

Analyst Michael Wiederhorn commented, "UNH reported 2Q15 EPS of $1.64 vs. our estimate of $1.57 and Street consensus... More

Leerink Partners Raises Price Market on UnitedHealth Group (UNH) Following 2Q EPS Beat

July 17, 2015 9:10 AM EDT

Leerink Partners maintained an Outperform rating on UnitedHealth Group (NYSE: UNH), and raised the price target to $160.00 (from $155.00), UNH posted a 6c EPS beat at $1.64. Revenues of $36.3b beat consensus estimates of $35.66b.

Analyst Ana Gupte commented, "UNH posted a 6c EPS beat in 2Q15 with an 8c EPS guidance raise. Revenues also beat, with guidance raised by $11B to reflect early close of the CTRX transaction, to $154B. The... More

Wedbush Raises Price Target on UnitedHealth Group (UNH) Following 2Q15 Results

July 17, 2015 8:47 AM EDT

Wedbush maintained an Outperform rating on UnitedHealth Group (NYSE: UNH), and raised the price target to $143.00 (from $138.00), following 2Q15 results. Analyst Sara James says that the Optum strategy to grow external sales and expand existing relationships is tracking in-line to better than expectations.... More

Mizuho Securities Raises Price Target on UnitedHealth Group (UNH) Following 2Q15 Results

July 17, 2015 8:16 AM EDT

Mizuho Securities maintained a Buy rating on UnitedHealth Group (NYSE: UNH), and raised the price target to $150.00 (from $146.00), following 2Q15 results. Analyst Sheryl Skolnick saw no real evidence of any problematic pricing, and says that upside was further "proof" that the "Optumization" of UNH continues.

Skolnick commented, "Clearly, analysts were... More

Mizuho Securities Maintains Buy on UnitedHealth Group (UNH) Following 2Q15 Results

July 16, 2015 8:18 AM EDT

Mizuho Securities maintains a Buy rating and $146.00 price target on UnitedHealth Group (NYSE: UNH) following 2Q15. UNH reported an EPS beat for 2Q of $1.64 vs Street's $1.59 estimate. Revenues of $36.3B Beat Street's $35.66B estimate.

Analyst Sheryl Skolnick commented, "UNH's results... More